Dficit mtabolique en vitamine B12 : une occasion manque de prvenir la dmence et l'accident vasculaire crbral L'tude se concentre sur l'importance et la prvalence de la carence mtabolique en vitamine B12, ainsi que sur ses facteurs contributeurs
CMAJ Can Med Assoc J journal de lAssociation medicale canadienne 185(10):E475E482
The 2026 Prohibited List took effect on 1 January 2026
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies
Treatment should be individualized rather than based only on which medication is currently more popular
Symptoms of deficiency, including fatigue, numbness, cognitive fog, and mood changes, may return over weeks to months
